Ultrasound opens Brain's door for Parkinson's drug
NCT ID NCT04370665
Summary
This small, early-stage study tested a new method to get medicine into the brain for Parkinson's disease. Researchers used focused ultrasound guided by an MRI to temporarily open the brain's protective barrier in four patients. They delivered a drug called Cerezyme three times to see if the procedure was safe and possible, and to check for any changes in symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
Conditions
Explore the condition pages connected to this study.